Kt/V underestimates the hemodialysis dose in women and small men  by Spalding, Elaine M. et al.
see commentary on page 262
Kt/V underestimates the hemodialysis dose in
women and small men
Elaine M. Spalding1, Shahid M. Chandna1, Andrew Davenport2 and Ken Farrington1
1Renal Unit, Lister Hospital, Coreys Mill Lane, Stevenage, Herts, UK and 2Renal Unit, Royal Free Hospital, Pond St, London, UK
Current guidelines suggest a minimum Kt/V of 1.2 for
three weekly hemodialysis sessions; however, using V as a
normalizing factor has been questioned. Parameters such as
weight0.67 (W0.67) and body surface area (BSA) that reflect the
metabolic rate may be preferable. To determine this,
we studied 328 hemodialysis patients (221 male) with a
target Kt/V of 1.2. Using this relationship and the individual’s
Watson Volume, we calculated the Kt, Kt/BSA, and Kt/W0.67
equivalent to the target and measured the effects of body
size and gender on these parameters for each patient. The
target corresponded to a range of equivalent Kt/BSA and
Kt/W0.67 each significantly higher in males than females
and in larger than smaller males. V/BSA and V/W0.67, the
conversion factors of Kt/V to Kt/BSA and Kt/W0.67
respectively, were significantly greater in males than females
and heavier than lighter men. Our study shows that if
Kt/BSA and Kt/W0.67 reflect the true required dose,
prescribing a target Kt/V of 1.2 would underestimate this
in females and in small males. Further work is required
to develop clinical outcome-based adequacy targets.
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Gotch and Sargent’s re-analysis of the National Cooperative
Dialysis Study established the dimensionless parameter
Kt/V as an index of hemodialysis (HD) adequacy, where
K was dialyzer urea clearance, V urea distribution volume
equating to total body water, and t duration of the HD
session.1 This parameter, derived from single-pool urea
kinetic modeling, has become the gold standard for HD
prescription and dose monitoring. Modifications to take
account of factors such as urea generation and two-pool
effects have become well accepted,2,3 and the concept of Kt/V,
as a marker of adequacy, has been extended to other
modalities, including peritoneal dialysis.4
V is an independent predictor of survival across the range
of delivered HD dose, an effect that has been attributed to
malnutrition in a poor-risk group of patients with low body
mass.5,6 Such findings have fueled criticism of the use of V
as the normalizing factor for Kt.7 Furthermore, there were
suggestions from the HEMO Study that women in the
intervention group (achieved two-pool Kt/V 1.53) had a
significantly lower mortality than those in the standard dose
group (achieved two-pool Kt/V 1.16).8 Though differences in
body size could not be implicated,9 the suspicion of a
denominator effect remains.
In prescribing HD, K is estimated from the urea mass
transfer coefficient (KoA) of the dialyzer together with the
anticipated blood and dialysis fluid flow rates. V is usually
estimated from anthropometric equations such as the Watson
formulae,10 though use of kinetic-based estimates may be
more desirable. In addition, the Watson V is often used to
estimate HD efficiency, a comparison of prescribed and
delivered dose. Estimating Watson V in male and female
subjects utilizes different equations that reflect known
differences in body composition. For any given age, height,
and weight, the calculated V is lower in women than in men.
Furthermore, the formulae for Watson V were based on data
from 30 different anthropometric studies selected to be
representative of a healthy Western population. The relevance
of these formulae to an aged, multiethnic, highly comorbid
HD population in which malnutrition and volume overload
are prevalent is perhaps questionable.
A further problem arises from the requirement for dialysis
to replicate renal excretion of metabolic waste products. It
might be expected that patients with higher metabolic rates
would require more dialysis than those with lower rates.
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Hence factors reflecting metabolic rate (‘metabolic size’)
might be more appropriate normalizing factors. It has been
suggested that the strongest single correlate of resting energy
expenditure (REE) is fat-free mass,11 and although there are
now simple non-invasive measurement techniques, use of
this parameter as a normalizing factor would require its serial
prospective measurement.12 Developing on this theme, it has
been suggested that the magnitude of the ratio of body cell
mass to fat-free mass is a major determinant of whole-body
REE.13 Recent work, although, has highlighted the contribu-
tion of the visceral organ mass, estimated by whole-body
magnetic resonance imaging, to resting energy metabolism
and uremic toxin production.14
There are simpler estimates of metabolic size. Basal
metabolism (P) is related to body mass (W, kg) by the
expression:
P ¼ aWb ð1Þ
Where a¼mass coefficient, which within a species is a
constant, b¼mass index, which within species approximates
to 0.67–0.7515–17
Body surface area (BSA) is also related to resting
metabolic rate, and correlates with body composition in
both sexes.18 Normalizing glomerular filtration rate to BSA is
standard practice. Normalizing dialyzer clearance in the same
way, would seem to be a logical extrapolation.
A common feature of the anthropometric formulae for
estimation of BSA, which is also a feature in Equation 1, is
the incorporation of body mass raised to an index, the value
of which is less than unity. Use of such parameters as the
normalizing factor has the effect of reducing the relative
importance of the denominator as body mass increases.
Patients with low body mass would require more dialysis per
unit mass than their heavier counterparts. This concept has
received support from groups deploying empirical and
theoretical approaches. Lowrie et al.7,19,20, using retrospective
registry data, investigated the relationships between outcome,
both derived and measured Kt, and a range of estimates of
body size. They found that increasing values of dialysis dose
and body size, however estimated, were both associated with
reduced mortality. Furthermore, Kt/BSA, unlike single-pool
and equilibrated Kt/V, was significantly associated with death
risk; patients with a low Kt/BSA having an increased hazard
ratio.19 A theoretical basis for these and similar observations
has been suggested and supported by the finding of a
proportionately larger visceral organ mass in smaller than in
larger patients.14,21 Hence REE and uremic toxin production
may be proportionately greater in smaller patients leading to
the requirement of a proportionately higher dialysis dose.
This may be compounded by their smaller muscle mass, and
hence their smaller volume of distribution for soluble uremic
toxins and by their smaller fat mass and hence their smaller
volume of distribution for fat-soluble uremic toxins. On all
these counts, smaller patients would be more susceptible to
the toxic effects of uremia.
This study was undertaken to evaluate the effect of
substituting BSA and W b for V as denominator in Kt/V,
on the distribution of target dialysis dose within our HD
population. We have generally considered b to be 0.67. The
use of V 0.67 as the normalizing factor for the in-center HD
arm of the ongoing NIH Frequent Haemodialysis Study lends
some justification for this choice.22 Given a target Kt/V of 1.2,
we sought to determine the equivalent HD dose expressed
in terms of Kt/BSA and Kt/W 0.67 and to determine the effect
of gender and body size on these relationships.
RESULTS
Patients
There were 328 patients, 221 men (age 62.3±15.1 years) and
107 women (age 62.7±14.5 years). Dialysis vintage was
1–253 months (mean 44.5±40.1). Mean anthropometric and
biochemical parameters are shown in Table 1.
Relationship between Watson volume, BSA, W 0.67, and
weight
The relationship between Watson volume and weight
(Figure 1) was best approximated by separate straight lines
for men (R2¼ 0.855) and women (R2¼ 0.960), which do not
pass through the origin and which diverge as weight
increases. The relationships between weight and BSA were
best approximated as a power function of the form y¼ aWb,
where a is a constant and b is a constant, the value of which
is less than unity. There is a small gender difference (a¼ 0.16,
b¼ 0.575, R2¼ 0.979 (men) and a¼ 0.16, b¼ 0.568,
R2¼ 0.982 (women)). The relationship between weight and
Wb is depicted in Figure 2 in a series of curves for values of b
between 0 and 1 (clearly a¼ 1 and R2¼ 1 for all cases, and
there is no gender differences).
Variation of V/BSA and V/W 0.67with gender and body weight
The quantities V/BSA and V/W 0.67 can be considered as
conversion factors of Kt/V to Kt/BSA and Kt/V 0.67 respec-
tively. Both ‘conversion factors’ were significantly greater in
men than in women (by 16 and 17.4% respectively; Po0.001
in both cases) and greater in larger (above mean V for men)
than in smaller men (by 6 and 3.7% respectively; Po0.001 in
Table 1 | Demographic and biochemical parameters of study
population
All patients Males Females P-value
Number 328 221 107
Age (years) 62.5±14.9 62.3±15.1 62.7±14.5 NS
Weight (kg) 71.3±15.9 75.2±15.3 63.1±14.0 o0.001
Height (m) 1.69±1.06 1.74±0.81 1.59±0.74 o0.001
Watson volume (l) 37.3±7.1 40.5±5.9 30.6±3.8 o0.001
Body surface area (m2) 1.83±0.24 1.91±0.221 1.67±0.21 o0.001
% Caucasian 80.5 82.3 76.6 NS
% Diabetes 20.5 22.6 15.0 NS
Hemoglobin
(g per 100 ml)
11.5±1.5 11.5±1.5 11.4±1.5 NS
Serum albumin (g/l) 33.7±5.2 33.9±5.3 33.4±4.7 NS
NS, not significant.
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both cases) (Figure 3). Smaller women (less than mean
women V) tended to have slightly higher values of both
parameters (0.5 and 3.5% respectively) than larger women
(significant for V/W 0.67; Po0.007).
Adequacy parameters equivalent to Kt/V of 1.2
The values of the adequacy parameters Kt, Kt/BSA, and
Kt/V 0.67, equivalent to a prescribed Kt/V of 1.2, are shown in
Figure 4 and Table 2. All parameters were bimodally distri-
buted with separate peaks for men and women (Figure 4),
and all were significantly greater in men (Table 2). All were
greater in patients in the upper tertile of body size (V) than
in those in the middle tertile. Likewise, those in middle tertile
were greater than in those in the lower (Table 3). While all
equivalent adequacy parameters were significantly greater in
larger (for definitions see above) than in smaller men, only
Kt was greater in larger than in smaller women. Kt/BSA in
women was independent of body size, while Kt/W 0.67 was
slightly but significantly greater in smaller than in large
women. The differences between mean Kt/BSA and Kt/W 0.67
in these four gender–body size groups and their degrees of
significance mirrored those described above for V/BSA and
V/W 0.67.
Body size, gender, and estimated ‘required’ target Kt
Figure 5 depicts the relationship in individual hemo-
dialysis (HD) patients between body size (Watson V) and
two values of ‘required’ target Kt, estimated as functions
of BSA according to the work of Lowrie et al.20 Figure 5A
demonstrates this relationship for the ‘double-reciprocal’
estimate and Figure 5B for the multiplicative estimate
(see Materials and Methods section and the figure legend
for detail). For both estimates, over the whole range of
encountered V, ‘required’ target Kt increases in a curvilinear
fashion with increasing V. There are also stark differences
between men and women with respect to their ‘required’
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Figure 2 | Relationship between Wb and dry weight. Separate
non-linear regression lines (of the form y¼ aWb) are shown for
a¼ 1, b¼ 0.1–1.0, at increments of 0.1. For details see text. Bold
lines represent the curves for b¼ 0.67 and b¼ 1. For clarity data
points omitted.
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Figure 3 | Relationship between Watson volume (V), body
surface area, and W 0.67 in 328 HD patients. Upper panel:
relationship between Watson V and body surface area in 328 HD
patients clustered into four groups—small women (omean V for
women), large women (4mean V for women), small men
(omean V for men), and large men (4 mean V for men).
*Po0.001 for comparison with all other groups. Lower panel:
relationship between Watson V and W0.67 in 328 HD patients
clustered into four groups—small women (omean V for women),
large women (4mean V for women), small men (omean V for
men), and large men (4mean V for men). *Po0.001 for
comparison with all other groups. Po0.007 for comparison
between small and large women. HD, hemodialysis.
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Figure 1 | Relationship between Watson volume (V) and dry
weight in 328 HD patients. The lines displayed represent best
linear regression fit in men and women. HD, hemodialysis.
350 Kidney International (2008) 74, 348–355
o r i g i n a l a r t i c l e EM Spalding et al.: Kt/V underestimates hemodialysis dose
target Kt. In very small patients, values of ‘required’ target Kt
are similar in women and men. However, in all but these
very small individuals, the required target is greater in
women and the gender difference increases with increasing
body size.
Target Kt/BSA and Kt/W0.67 values equivalent to a range of
target Kt/V values
Mean equivalent Kt/BSA and Kt/W0.67 for target Kt/V
between 0.7 and 1.7 are shown in Figure 6 in relation to
gender and body size. For all target Kt/V, mean equivalent
Kt/BSA and Kt/W0.67 levels were significantly greater in men
than in women, the differences increasing with target Kt/V.
They were also significantly greater in large than in small
men, the differences increasing with target Kt/V. In women,
there was no difference between equivalent Kt/BSA in large
and small individuals, while equivalent Kt/W0.67 was consis-
tently slightly greater in smaller women. The effect was small
but increased with target Kt/V. These differences again
mirrored those described above for V/BSA and V/W0.67.
Range of Kt/Wb equivalent to Kt/V of 1.2
Figure 7 shows the relationship between the values of Kt/Wb
equivalent to a Kt/V of 1.2 and corresponding values of Wb,
for values of b between 0 and 1. On right side of each panel
as W1¼W, Kt/Wb¼Kt/W, which is directly proportional to
Kt/V. On the left side of each panel, as W0¼ 1, Kt/Wb¼Kt.
The upper panel demonstrates the effect of gender on this
relationship. Mean Kt/Wb in women is expressed as a
proportion of the value in men. When b¼ 1, equivalent
Kt/W is 10% less in women than in men. As b decreases, the
gender difference in Kt/Wb increases, so that at b¼ 0, mean
equivalent Kt was 24.6% lower in women. The middle panel
depicts Kt/Wb in relation to Wb in the three tertiles of body
size (V), expressed as a percentage of values in the middle
tertile. As b decreases, equivalent Kt/Wb increases in the
upper tertile and decreases in the lower tertile. The lower
panel depicts the combined effects of gender and size on
equivalent Kt/Wb. The relationship is more complex. The
dashed vertical lines in each panel represent the values of b,
0.5378 (the exponent of weight in the Haycock BSA) and
0.67. At these levels of weight exponent, both gender and
body size have a potentially major impact on target HD
adequacy expressed as Kt/BSA or Kt/W0.67.
DISCUSSION
More than average weight patients have a survival
advantage.5,23,24 This has been attributed to an excess morta-
lity in those with low body mass index, due to malnutrition
and cachexia,5,6 though the effect persists after adjustment
for comorbidity, diabetes, and morbid obesity.24 Our study
suggests that other factors may contribute to the excess
mortality in smaller patients. If the appropriate normalizing
factor for the required dialysis dose were metabolic size (BSA
or W 0.67) rather than body mass (W), the relative importance
of the normalizing factor in determining the target HD dose
(Kt/BSA or Kt/W 0.67) would be greater in smaller indivi-
duals. Hence use of V as the normalizing factor in prescribing
dialysis would tend to result in inadequate treatment for
smaller patients, as has been previously suggested.7,19,20
Recent observations suggesting that smaller patients
may have disproportionately higher rates of uremic toxin
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Figure 4 | Histograms of distribution by gender of Kt
(upper panel), Kt/BSA (middle panel), and Kt/W0.67 values
(lower panel) equivalent to target Kt/V of 1.2 in 328
hemodialysis patients.
Table 2 | Adequacy parameters equivalent to prescribed Kt/V
of 1.2, by gender
Parameter Whole group Male Female P-value
Kt (l) 44.7±8.4 48.7±7.1 36.7±4.5 o0.001
Kt/BSA (l/m2) 24.3±2.0 25.5±1.4 21.9±0.3 o0.001
Kt/W0.67 (l/kg0.67) 2.57±0.23 2.70±0.15 2.30±0.09 o0.001
Table 3 | Adequacy parameters equivalent to prescribed
Kt/V of 1.2, by tertiles of body size (V)
Tertiles of V
Parameter Lower Middle Upper P-value
Kt (l) 35.7±3.2 44.5±2.2 54.1±5.6 o0.001
Kt/BSA (l/m2) 22.4±1.2 24.4±1.5 26.2±1.1 o0.001
Kt/W0.67 (l/kg0.67) 2.38±0.17 2.59±0.21 2.75±0.15 o0.001
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production, coupled with lower volumes of distribution, than
their larger peers,14,21 provide a strong theoretical basis for
the use of an alternative denominator in dialysis prescription.
This denominator should reflect the rate of production
of uremic toxins, and not just their volume of distribution.
Our use of BSA and W0.67 may represent a step toward
this goal.
Previous empirical analysis has clearly demonstrated a
strong curvilinear relationship between outcome-defined
target Kt and BSA.20 Although best described statistically by
a double-reciprocal relationship (KtDR; see Equation 5), the
relationship can also be described by a power function
(KtM¼ 34.6BSA0.63; see Equation 6). This empirically
derived expression is similar to our starting premise, which
was based on the hypothetical relationship between target
Kt and P, which can be represented as a power function of
weight (P¼aWb: from Equation 1, where we have generally
taken b¼ 0.67). Though these exponents are similar, it
should be noted that BSA is also related to W 0.54 (in the
Haycock formula), hence KtM is approximately related to
W 0.36. Our use of Wb and BSA as alternative denominators
(to V) for dialysis dose has allowed us to demonstrate that
patients of different body size and gender, dialyzed to the
same target Kt/V, may be receiving significantly different
treatment doses, when these are quantified by other means.
What we have not done is to define a putative target dialysis
dose expressed in terms of Kt/BSA or Kt/Wb. This would need
to be determined by rigorous analysis of outcome data, as has
been previously undertaken in the evaluation of target
KtDR.
25 Previous work has also shown that low levels of
Kt/BSA may be associated with increased mortality risk.19
Extrapolating from Figure 5, Lowrie et al.19 would suggest an
increased hazard ratio when Kt/BSA o23 l/m2. The same
figure suggests that high levels of Kt/BSA may also confer a
slightly increased mortality risk,19 though this is less clear
and further work is required on this issue.
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Body size is clearly important in determining required
dialysis dose, but alone does not explain the bimodal distri-
bution observed in our plots of equivalent Kt/BSA and
Kt/W0.67. These point to a specific effect of gender and reflect
the different relationship between V and BSA in men and
women. This is also apparent from our plots of ‘required’
target Kt against V (Figure 5), which suggest that for a given
level of V, the required target dialysis dose is greater in
women than in men. These gender differences relate to an
increased adipose tissue-to-fat-free mass ratio in women,
who therefore have disproportionately low V for their body
size. The different formulae for Watson V for men and
women reflect this and predict that for any given age, height,
and weight, calculated V is lower in women than in men. It
may be that these formulae do not accurately reflect total
body water in uremic men or women or both, and that the
bimodal distribution is artefactual. In this case, use of a
kinetic V in dialysis prescription would be more appropriate.
If, as is likely, Watson V does reflect total body water in this
population, then the bimodal distribution represents a true
gender difference, and the same concerns would arise even
with use of a kinetic V in dialysis prescription. It seems that
visceral mass, which reflects the high metabolic rate compart-
ment, may have a similar relationship to body size in men and
women.14 Hence, it may be that effects of body size and gender
on required dialysis dose have different pathophysiological
bases, the influence of body size being mediated through its
non-linear relationship with uremic toxin production, and
that of gender, through gender-related differences in uremic
toxin distribution volume.
Use of BSA or W0.67 as the normalizing factor for HD
prescription may represent a more physiological starting point,
but many of the issues discussed above demonstrate the need to
refine and validate the concept before it can be used in the
clinical arena. There are other potential problems. BSA or W 0.67
relate only to basal metabolic requirements, while the genera-
tion of metabolic waste must relate to total energy expenditure.
Total energy expenditure consists of REE plus physical activity
energy expenditure plus the thermic effect of food.26 Thermic
effect of food is relatively small but in some individuals, physical
activity energy expenditure may be very significant. Very active
individuals generate more metabolic waste than sedentary
individuals and by this reasoning may require more dialysis.
With increasing catabolism, relating, say to underlying
sepsis or extra-renal comorbidity, the requirement for dialysis
would also be expected to increase. This can be conjectured
as a requirement to normalize dialysis dose by values of Wb
in which the value of b is decreasing from b¼ 1, when the
required dialysis dose¼Kt/W which is proportional to Kt/V,
to b¼ 0, when the required dialysis dose¼Kt (Figure 6). As
catabolic rate increases (and b decreases), the disparities
relating to gender and body size are amplified. Catabolic
patients require more dialysis, and smaller patients and
women may require a greater proportional increase.
In the general population, basal metabolic rate appears to
be around 5% lower in women than in men, at least in
sedentary women over 50 years of age.27 This may offset some
of the effects we have described. However, in dialysis patients,
in whom REE may be increased, a sex difference in basal
metabolic rate was not apparent, though the numbers studied
were small.28 In addition, recent work in the HD population
has suggested that women have an REE (normalized to
fat-free mass) that is 6% higher than that in men.14
Women in the high-target group (two-pool Kt/V 1.53) in
HEMO study had a 19% lower mortality than those in the
standard-target group (two-pool Kt/V 1.16)8 in contrast to
the findings in the group overall. Extrapolating our findings
concerning equivalent Kt/BSA, a two-pool Kt/V of 1.16 in
women is equivalent to approximately 0.96–1.02 in a large
male patient, while a two-pool Kt/V of 1.53 is equivalent to
approximately 1.26–1.32 in a large male patient. In terms of
equivalent Kt/BSA therefore, women in the high-target group
received a similar dose to men in the standard group, whereas
women in the low-target group could be regarded as having
been underdialyzed.
Current UK guidelines recommend a minimum equili-
brated Kt/V (eKt/V) of 1.2, and suggest that to achieve this
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‘metabolic size’.BSA, body surface area; HD, hemodialysis.
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consistently, target eKt/V should be 1.4. If in large men, mini-
mum eKt/V is 1.2 and target eKt/V is 1.4, then our findings
suggest that for women, these values should be around 16%
higher at 1.39 and 1.62 respectively. By the same reasoning, in
small men, values for these parameters should be at least 6%
higher at 1.27 and 1.48. These differing eKt/V doses deliver
the same dose expressed as Kt/BSA. These suggestions are
in line with the recommendations of the recent K-DOQI
guidelines for hemodialysis, which advise giving considera-
tion to increasing minimum dialysis dose targets for small
patients and for women.29 Further work is required to
develop these concepts and to translate them into rigorous
outcome-based adequacy targets suitable for clinical usage.
MATERIALS AND METHODS
Patients
We studied all patients receiving HD in the Lister Renal unit on
first April 2005. Patients were treated exclusively using high-flux
synthetic membranes, ultra-pure water, and bicarbonate buffer. A
high proportion received on-line hemodiafiltration. Target Kt/V
(two-pool) was 1.2 per HD session.30
Data gathering
The following information was collected for all patients from
computer-held records:
K Age
K Sex
K Height (cm)
K Target weight (W, kg)
K V was derived from the Watson formula10
V ¼ 2:447  0:09516A þ 0:1074H
þ 0:3362W litres ðmalesÞ ð2Þ
¼ 2:097 þ 0:1069H þ 0:2466W litres ðfemalesÞ ð3Þ
where A¼ age (years), H¼ height (cm), W¼weight (kg)
K Serial body surface area (BSA (m2)), derived from the Haycock
formula31
BSA ðm2Þ ¼ W0:5378H0:39640:024265 ð4Þ
where H¼ height (cm), W¼weight (kg)
K Target Kt
Kt ¼ 1:2V
K Target Kt/BSA
K Target Kt/Wb
where b¼ 0.67 and other values as appropriate.
Estimates of ‘required’ target Kt
Estimates of ‘required’ target Kt were calculated using two
previously published empirically derived formulae based on
BSA.20 These were a double-reciprocal estimate (KtDR) and a
multiplicative estimate (KtM). Both are shown below.
KtDR ¼ 1=ða þ b=BSAÞ; where a ¼ 0:0069 and b ¼ 0:0237 ð5Þ
KtM ¼ a  BSAb; where a ¼ 34:6 and b ¼ 0:63 ð6Þ
Statistical analysis
Values are expressed ±1 standard deviation unless otherwise
stated. Methods utilized were analysis of variance with Bonferroni
method for post hoc comparisons, Students t-test, and w2 analysis
as appropriate. Results were deemed to be significant at a P-value of
o0.05. The statistical packages used were SPSS 15 and Systat 9.
GraphPad was used for curve fitting.
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